Total medical devices industry M&A deals in March 2019 worth $817.9m were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked a decrease of 86.1% over the previous month and a drop of 72.3% when compared with the last 12-month average, which stood at $2.95bn.

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $507.48m. At the country level, the US topped the list in terms of deal value at $507.48m.

In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in March 2019 was the US with 20 deals, followed by Germany with three and Canada with two.

In 2019, as of the end of March 2019, medical devices M&A deals worth $8.22bn were announced globally, marking an increase of 41.8% year on year.

Medical devices industry M&A deals in March 2019: Top deals

The top five medical devices industry M&A deals accounted for 98.7% of the overall value during March 2019.

The combined value of the top five medical devices industry M&A deals stood at $807.49m, against the overall value of $817.9m recorded for the month. The top announced medical devices industry M&A deal tracked by GlobalData in March 2019 was Alcon Laboratories’ $285m acquisition of PowerVision.

In second place was the $220m acquisition of MyoScience by Pacira Pharmaceuticals and in third place was Stryker‘s $220m acquisition of Ortho-Space.

The $76.74m acquisition of Direct Conversion by Varex Imaging and Shantou Dongfeng Printing’s acquisition of Guizhou Chienyeh Pharmaceutical Packaging for $5.75m held fourth and fifth positions, respectively.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.